Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.

SUMMARY: Antidepressants have been associated with fractures. In a case-control study, increasing age was associated with more fractures in users of selective serotonin reuptake inhibitors and tricyclic antidepressants, whereas for anxiolytics and sedatives, more fractures were seen among the young...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Vestergaard, P, Prieto-Alhambra, D, Javaid, M, Cooper, C
Format: Journal article
Język:English
Wydane: 2013
_version_ 1826281952416628736
author Vestergaard, P
Prieto-Alhambra, D
Javaid, M
Cooper, C
author_facet Vestergaard, P
Prieto-Alhambra, D
Javaid, M
Cooper, C
author_sort Vestergaard, P
collection OXFORD
description SUMMARY: Antidepressants have been associated with fractures. In a case-control study, increasing age was associated with more fractures in users of selective serotonin reuptake inhibitors and tricyclic antidepressants, whereas for anxiolytics and sedatives, more fractures were seen among the younger users. Depression per se did not seem associated with fractures. INTRODUCTION: This study aims to study the effects of age and dose of selective serotonin reuptake inhibitors (SSRI), tricyclic antidepressants (TCA) and anxiolytics/sedatives on fracture risk. METHODS: The study was designed as a case-control study. From the Danish National Health Service, we identified 124,655 fracture cases and 373,962 age- and gender-matched controls. Crude odds ratios were estimated, and propensity score adjustment was used to minimise confounding by indication. RESULTS: A higher risk of fractures was associated with an increasing dose of anxiolytics and sedatives; the highest excess risk was present in the age stratum below 40 years of age (p < 0.01), and thereafter, the excess risk of fractures declined with age. For SSRI, a growing excess risk of fractures was seen with both increasing dose and age. Regarding TCA, no particular trend with age was present. However, an increasing risk of fractures was associated with increasing TCA dose in the age group above 60 years. Finally, for other antidepressants, no particular trend with age or dose was observed. In our data, a hospital diagnosis of depression or manic depression was associated with fewer fractures. CONCLUSION: Caution should be shown upon prescription of SSRI to older subjects. A hospital diagnosis of depression or manic depression and thus potentially a more severe disease was not a risk factor for fractures.
first_indexed 2024-03-07T00:36:33Z
format Journal article
id oxford-uuid:819e1d82-b49b-40ab-9f16-6b5da44f2e7f
institution University of Oxford
language English
last_indexed 2024-03-07T00:36:33Z
publishDate 2013
record_format dspace
spelling oxford-uuid:819e1d82-b49b-40ab-9f16-6b5da44f2e7f2022-03-26T21:31:24ZFractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:819e1d82-b49b-40ab-9f16-6b5da44f2e7fEnglishSymplectic Elements at Oxford2013Vestergaard, PPrieto-Alhambra, DJavaid, MCooper, C SUMMARY: Antidepressants have been associated with fractures. In a case-control study, increasing age was associated with more fractures in users of selective serotonin reuptake inhibitors and tricyclic antidepressants, whereas for anxiolytics and sedatives, more fractures were seen among the younger users. Depression per se did not seem associated with fractures. INTRODUCTION: This study aims to study the effects of age and dose of selective serotonin reuptake inhibitors (SSRI), tricyclic antidepressants (TCA) and anxiolytics/sedatives on fracture risk. METHODS: The study was designed as a case-control study. From the Danish National Health Service, we identified 124,655 fracture cases and 373,962 age- and gender-matched controls. Crude odds ratios were estimated, and propensity score adjustment was used to minimise confounding by indication. RESULTS: A higher risk of fractures was associated with an increasing dose of anxiolytics and sedatives; the highest excess risk was present in the age stratum below 40 years of age (p < 0.01), and thereafter, the excess risk of fractures declined with age. For SSRI, a growing excess risk of fractures was seen with both increasing dose and age. Regarding TCA, no particular trend with age was present. However, an increasing risk of fractures was associated with increasing TCA dose in the age group above 60 years. Finally, for other antidepressants, no particular trend with age or dose was observed. In our data, a hospital diagnosis of depression or manic depression was associated with fewer fractures. CONCLUSION: Caution should be shown upon prescription of SSRI to older subjects. A hospital diagnosis of depression or manic depression and thus potentially a more severe disease was not a risk factor for fractures.
spellingShingle Vestergaard, P
Prieto-Alhambra, D
Javaid, M
Cooper, C
Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
title Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
title_full Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
title_fullStr Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
title_full_unstemmed Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
title_short Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
title_sort fractures in users of antidepressants and anxiolytics and sedatives effects of age and dose
work_keys_str_mv AT vestergaardp fracturesinusersofantidepressantsandanxiolyticsandsedativeseffectsofageanddose
AT prietoalhambrad fracturesinusersofantidepressantsandanxiolyticsandsedativeseffectsofageanddose
AT javaidm fracturesinusersofantidepressantsandanxiolyticsandsedativeseffectsofageanddose
AT cooperc fracturesinusersofantidepressantsandanxiolyticsandsedativeseffectsofageanddose